back to index for this section
|
Business and Human Rights: a resource website |
|
Pharmaceutical companies: 1993-2000 |
See also other materials on "Pharmaceutical companies"
2000:
Europe and UK hampering Third World's fight on Aids (Alex Duval Smith, Independent [UK], 5 Dec. 2000)
Institute releases report on intellectual property and HIV/AIDS pharmaceuticals: Report focuses on sub-Saharan Africa and the Role of Patents (International Intellectual Property Institute, 1 Dec. 2000)
Patents, High Prices Keep Essential Drugs Out Of Reach (Anaclet Rwegayura, Panafrican News Agency, 25 Oct. 2000)
Integrating Public Health Concerns into Patent Legislation in Developing Countries (Carlos Correa, University of Buenos Aires, Argentina, Oct. 2000)
TRIPS and pharmaceuticals: A case of corporate profits over public health (Cecilia Oh, Third World Network, 30 Sep. 2000)
Swiss firms seek protection against Nazi slave labor lawsuits (Alexander Higgins, Associated Press, 17 Sep. 2000)
Speech by Ralph Nader about the power of multinational corporations (Ralph Nader, founder of Public Citizen, presentation to United Nations DPI/NGO conference on "Global Solidarity: The way to peace and International Cooperation", 28-30 Aug. 2000)
Oxfam calls $1b drug deal "a debt for tomorrow's AIDS orphans" (Oxfam GB, 21 July 2000)
AFRICA-AIDS: U.S. drug offer is criticised (IRIN/Integrated Regional Information Networks, 20 July 2000)
MSF calls for rapid action on access to HIV/AIDS treatment (Medecins sans frontieres/Doctors Without Borders, 13 July 2000)
Activists discount big drugmakers' gifts (Steve Sternberg, USA Today, 11 July 2000)
Aids: The disease ten times as deadly as war (Sarah Boseley, Guardian [UK], 8 July 2000)
Keeping up the pressure on the pharmaceutical industry (Jacky Delorme, Trade Union World, 15 June 2000)
Panel of Independent Judges Selects Six Companies for their Outstanding Responsible Business Practices (Council on Economic Priorities, June 2000)
Narrowing the 10/90 Gap in Health Research: Less than 10% of the estimated US$56 billion spent annually on health research by the public and private sectors is devoted to diseases or conditions that account for 90% of the global burden of disease. This economically costly and socially unfair situation is at the heart of the 10/90 Report on Health Research 2000, released here today by the Global Forum for Health Research. (Global Forum for Health Research, 2 May 2000)
Public-private partnerships: illustrative examples: two examples of public-private partnerships: UNDP / World Bank / WHO Special Programme for Research and Training in Tropical Diseases (TDR); Philanthropic drug donation programmes (Adetokunbo Lucas, Chair of the Foundation Council of the Global Forum for Health Research, April 2000)
The business response to HIV/AIDS: impact and lessons learned [Section 5, "Profiles of business activities in response to HIV/AIDS", includes profiles of American International Assurance, Thailand; The Body Shop, Japan; Warsaw Marriott Hotel; Larsen & Toubro, India; Volkswagen do Brasil; Molson Breweries, Canada; Chevron Nigeria; Standard Chartered Bank, UK; International Hotel & Restaurant Association; Anglo Coal, South Africa; Eskom, South Africa; ALMS, Czech Republic; Teddy Exports, India; Bristol Myers Squibb, USA; The Shell Company of Thailand] (Prince of Wales International Business Leaders Forum in collaboration with UNAIDS and Global Business Council on HIV/AIDS, 2000)
Council on Economic Priorities Names the Industry Leaders for the Year 2000 [Campaign for Cleaner Corporations] (Council on Economic Priorities, 2000)
1999:
Breakthrough: $5.2 Billion Settlement Reached in Nazi Slave Labor Case (Burt Herman, Associated Press, 15 Dec. 1999)
Impacts of WTO On The Environment, Cultures and Indigenous Peoples (Victoria Tauli-Corpuz, Director of Tebtebba Foundation [Indigenous Peoples' International Centre for Policy Research and Education] and Convenor of Asia Indigenous Women's Network, 29 Nov. 1999)
Compulsory Licensing and Parallel Importing: What do they mean? Will they improve access to essential drugs for people living with HIV/AIDS? (Margaret Duckett, International Council of AIDS Service Organizations [ICASO], July 1999)
Headaches for Bayer: Auschwitz Survivor Says Pharmaceutical Giant Aided Nazis (ABCNEWS.com, 11 June 1999)
The World's Indigenous Peoples (Russel Barsh, White Paper commissioned by Calvert Group Funds, 1999)
Sustainable Development at the Turn of the Century: Perception, Reality, and Outlook (Prof. Dr. Klaus M. Leisinger, Novartis Foundation, 1999)
Development Assistance at the Threshhold of the 21st Century (Prof. Dr. Klaus M. Leisinger, Novartis Foundation, 1999)
1998:
Kerala Tribe Accuses Indian Biologists of Stealing Knowledge [India] (J. John and Sindhu Menon, Panos, 6 Aug. 1998)
1997:
INDIA-TRADE: Bio-Piracy Campaign Exposes Holes in U.S. Patent Laws (Bijoy Basant Patro, Inter Press Service, 4 Sep. 1997)
1995:
Sustainable Development and Good Governance (Prof. Dr. Klaus M. Leisinger, Novartis Foundation, 1995)
1994:
Sustainable Development: A Common Challenge for North and South (Prof. Dr. Klaus M. Leisinger, Novartis Foundation, 1994)
1993:
The Effect of Multinational Companies on Development (Prof. Dr. Klaus M. Leisinger, Novartis Foundation, 1993)